HKPD
HKPD
NASDAQ · Logistics & Transportation

Cellyan Biotechnology Co-A

$0.53
-0.04 (-6.98%)
As of May 16, 2:31 AM ET ·
Financial Highlights (FY 2026)
Revenue
13.50M
Net Income
-29,564
Gross Margin
21.8%
Profit Margin
8.0%
Rev Growth
D/E Ratio
0.48
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 21.8% 50.8% 50.8% 50.8%
Operating Margin 8.3% 13.2% 12.8% 14.3%
Profit Margin 8.0% 10.5% 9.0% 11.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 13.50M 7.40M 6.68M 7.22M
Gross Profit 2.94M 3.76M 3.39M 3.67M
Operating Income 1.12M 979.4K 856.8K 1.03M
Net Income -29,564 776.7K 602.4K 808.7K
Gross Margin 21.8% 50.8% 50.8% 50.8%
Operating Margin 8.3% 13.2% 12.8% 14.3%
Profit Margin 8.0% 10.5% 9.0% 11.2%
Rev Growth +0.0% +3.7% -6.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.01M 3.92M 3.96M 4.01M
Total Equity 2.12M 6.40M 7.03M 7.28M
D/E Ratio 0.48 0.61 0.56 0.55
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 1.35M 1.39M 1.13M 1.38M
Free Cash Flow 667.3K 430.6K 626.2K